THA Clinical Trials

285 recruitingLast updated: May 29, 2026

There are 285 actively recruiting tha clinical trials across 55 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3, Early Phase 1. Top locations include New York, New York, United States, Houston, Texas, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


THA Trials at a Glance

285 actively recruiting trials for tha are listed on ClinicalTrialsFinder across 6 cities in 55 countries. The largest study group is Not Applicable with 78 trials, with the heaviest enrollment activity in New York, Houston, and Boston. Lead sponsors running tha studies include Shanghai Changzheng Hospital, National Taiwan University Hospital, and Institute of Hematology & Blood Diseases Hospital, China.

Treatments under study

About THA Clinical Trials

Looking for clinical trials for THA? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new THA trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about THA clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 285 trials

Recruiting
Phase 1Phase 2

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Beta-ThalassemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI)90 enrolled1 locationNCT07599176
Recruiting
Phase 1

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Sickle Cell DiseaseHb-SS DiseaseHemoglobin S+3 more
National Heart, Lung, and Blood Institute (NHLBI)25 enrolled1 locationNCT05904093
Recruiting
Phase 3

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Beta-ThalassemiaMyelodysplastic Syndromes (MDS)Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene665 enrolled143 locationsNCT04064060
Recruiting
Phase 2

A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea

Functional Hypothalamic Amenorrhea (FHA)
Regeneron Pharmaceuticals34 enrolled6 locationsNCT07235917
Recruiting
Phase 1

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Recurrent Chronic Myelomonocytic LeukemiaRefractory Chronic Myelomonocytic LeukemiaRecurrent High Risk Myelodysplastic Syndrome+4 more
M.D. Anderson Cancer Center38 enrolled1 locationNCT03896269
Recruiting
Not Applicable

Self-Adhering Magnetic Device to Treat Corneal Exposure

Paralytic LagophthalmosCorneal Exposure
University of Illinois at Chicago25 enrolled1 locationNCT06291818
Recruiting

Change of Knee Phenotype After Total Hip Arthroplasty

Knee Phenotype Changes After THACoronal Plane Alignment of the Knee
Nader Ahmed Sayed Abdelhamed500 enrolled1 locationNCT07597538
Recruiting
Phase 2

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

AlbuminuriaSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
University of Illinois at Chicago20 enrolled1 locationNCT07175051
Recruiting
Phase 3

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

methamphetamine abuseMethamphetamine Dependence
National Institute on Drug Abuse (NIDA)360 enrolled11 locationsNCT06233799
Recruiting
Not Applicable

GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors

Patients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to Radiation
Sir Mortimer B. Davis - Jewish General Hospital50 enrolled1 locationNCT02333110
Recruiting
Phase 1Phase 2

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

Advanced Solid Tumors That Are MTAP Deficient
AstraZeneca334 enrolled20 locationsNCT06130553
Recruiting

New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss

Hearing Loss, Bilateral (Causes Other Than Tumors)
University of Southern California100 enrolled2 locationsNCT06781749
Recruiting
Not Applicable

PrEP Readiness Interventions for Sustained Motivation (PRISM)

HIVMethamphetamine Disorders
Florida International University400 enrolled1 locationNCT06637436
Recruiting
Phase 4

The Research of Integrated Traditional Chinese and Western Medicine on Hypothalamic Amenorrhea

Functional Hypothalamic Amenorrhea
Peking Union Medical College Hospital210 enrolled1 locationNCT07580950
Recruiting

National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

AniridiaAlbinismCorneal Dystrophy+4 more
National Eye Institute (NEI)1,000 enrolled2 locationsNCT06491615
Recruiting

Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children

AnophthalmiaMicrophthalmiaColoboma
Baylor College of Medicine3,000 enrolled1 locationNCT06293560
Recruiting

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Sickle Cell DiseaseMalariaAlpha and Beta Thalassemia+1 more
National Institute of Allergy and Infectious Diseases (NIAID)300 enrolled1 locationNCT03937817
Recruiting
Not Applicable

Binaural Beats for Postoperative Pain and Anxiety Reduction

AnxietyTotal Hip Arthroplasty (THA)Total Knee Replacement+6 more
University of Miami50 enrolled1 locationNCT07437469
Recruiting
Not Applicable

Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthroplasty

Postoperative Pain ManagementTotal Hip Arthroplasty (THA)PENG Block+2 more
University of Liege118 enrolled1 locationNCT06964282
Recruiting
Phase 2

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

GerminomaBasal Ganglia GerminomaDiabetes Insipidus+3 more
Children's Oncology Group240 enrolled109 locationsNCT06368817